2021 H1 NGS newsletter
2021 is turning out to be the year of recovery, rebound, and realignment. With refreshes and new additions to the ThruPLEX and SMART-Seq product lines, Takara Bio continues to provide you with first-rate products for all your NGS needs. Read on to learn more about what our NGS community has been up to so far.
May
Key publications
Modeling and targeting of erythroleukemia by hematopoietic genome editing. Learn more »
April
Key publications
NanoSINC-seq dissects the isoform diversity in subcellular compartments of single cells. Learn more »
Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues. Learn more »
Developmental HCN channelopathy results in decreased neural progenitor proliferation and microcephaly in mice. Learn more »
March
Key publications
sncRiboTag-Seq: cell-type-specific RiboTag-Seq for cells in low abundance in mouse brain tissue. Learn more »
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma. Learn more »
February
Key publications
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis. Learn more »
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Learn more »
Functional states in tumor-initiating cell differentiation in human colorectal cancer. Learn more »
Product information
January
Key publications
Development a multiplex RT-PCR assay for simultaneous detection of African swine fever virus, classical swine fever virus and atypical porcine pestivirus. Learn more »
UniverSC: a flexible cross-platform single-cell data processing pipeline. Learn more »
A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor-positive breast cancer. Learn more »
Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer. Learn more »
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Learn more »
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Learn more »
LEAFY is a pioneer transcription factor and licenses cell reprogramming to floral fate. Learn more »
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Learn more »
Product information
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
